Inactivation of SARS-CoV-2 Laboratory Specimens #MMPMID33878029
Haddock E; Feldmann F; Shupert WL; Feldmann H
Am J Trop Med Hyg 2021[Apr]; 104 (6): 2195-2198 PMID33878029show ga
The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation procedures that verify their effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).